Ovarian Cancer Research Laboratory

Research Summary: 

The Ovarian Cancer Laboratory at the University of Chicago, founded in 2004, is dedicated to improving our understanding of the biology of ovarian cancers, including high-grade serous, low-grade serous and clear cell carcinoma to identify new therapeutic options for patients. We have a collaborative environment in the laboratory, where scientists, postdocs, physicians, fellows and students work together to answer critical questions in ovarian cancer biology. We meet once a week to discuss research results and new ideas or listen to an invited speaker in our field. The laboratory is directed by Ernst Lengyel, MD, PhD, a clinically active gynecologic oncologist with a special focus on the surgical treatment of ovarian cancer, and Hilary Kenny, PhD, a Research Associate Professor whose work focuses on elucidating the role of the tumor microenvironment in ovarian cancer development and metastasis. Drs. Lengyel and Kenny have worked together successfully since 2005.

Ovarian cancer is the sixth leading cause of cancer death among women in the United States. The high fatality of the disease is because it is often diagnosed at a late stage when tumor cells have disseminated within the peritoneal cavity. Unfortunately, despite aggressive treatment, most patients have an incurable recurrence at some point in their cancer journey. For clinical information about ovarian cancer and ovarian mass treatments, please visit the University of Chicago Medicine’s Gynecologic Oncology webpage. View publications for Dr. Ernst Lengyel and Dr. Hilary Kenny.

Main projects in the laboratory:

Our research is bedside to bench using primary human and cultured cells of the normal microenvironment (epithelial, fibroblasts, mesothelial cells, adipocytes, and immune cells) and tumor microenvironment (cancer and cancer-associated stromal cells), parallel to mouse models of ovarian cancer (xenograft, syngeneic, and genetic). Interactions between cancer cells and the microenvironment are investigated in vitro using novel organotypic 3D cultures. We have also assembled tissue micro arrays (TMA) of primary and metastatic ovarian cancers. These tissue samples are linked to a database containing clinico-pathologic information on all ovarian cancer patients operated on at the University of Chicago since 1992.

Collaborations:

To reach our goals, we have formed important collaborations with physicians and scientists. The common goal of everybody working in or with our laboratory is to transfer knowledge from the laboratory to the clinical arena, so we may improve the survival of women suffering from ovarian cancer. Our collaborators include: 

Join the Ovarian Cancer Laboratory: 

We have job openings for research assistants and postdoctoral scientists. Email us your CV if you're interested in joining our team: lengyeloffice@bsd.uchicago.edu. 

Funding: